These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28687825)

  • 1. Conflict of Interest, Conflicting Interests, and Effective Collaboration Between Academia and Industry on Preclinical and Clinical Cancer Research.
    Rothenburg ML; Johnson DH
    JAMA Oncol; 2017 Dec; 3(12):1621-1622. PubMed ID: 28687825
    [No Abstract]   [Full Text] [Related]  

  • 2. [What ethics for citizen science?].
    Ficorilli A
    Epidemiol Prev; 2019; 43(2-3):124-125. PubMed ID: 31293129
    [No Abstract]   [Full Text] [Related]  

  • 3. Principles and considerations for effective academia-industry collaboration in pharmacoepidemiology.
    Ephross SA; Mitchell AA; Sacks S; Straus W; Stürmer T
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1153-1156. PubMed ID: 30232825
    [No Abstract]   [Full Text] [Related]  

  • 4. How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, California.
    Rosenblatt M
    Ann Am Thorac Soc; 2013 Feb; 10(1):31-8. PubMed ID: 23509330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 7. Strengthened ties between industry and academia are historical, productive, and crucial.
    Haller JA
    Surv Ophthalmol; 2014; 59(3):348-53. PubMed ID: 24656436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
    Mavilio F
    Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At issue: A model for academic/industry collaboration.
    Carpenter WT; Koenig JI; Bilbe G; Bischoff S
    Schizophr Bull; 2004; 30(4):997-1004. PubMed ID: 15954203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is industry money the root of all conflicts of interest in biomedical research?
    Caplan AL
    Ann Emerg Med; 2012 Feb; 59(2):87-8. PubMed ID: 21459479
    [No Abstract]   [Full Text] [Related]  

  • 11. Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.
    Broes S; Saesen R; Lacombe D; Huys I
    Clin Transl Sci; 2021 Jan; 14(1):47-53. PubMed ID: 32799428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industrial collaboration.
    Rosoff PM
    N Engl J Med; 2003 Feb; 348(9):863-4; author reply 863-4. PubMed ID: 12606747
    [No Abstract]   [Full Text] [Related]  

  • 13. Research Projects Supported by the University of California, San Francisco-Stanford Center of Excellence in Regulatory Science and Innovation.
    Giacomini KM; Lin L; Altman RB
    Clin Pharmacol Ther; 2019 Apr; 105(4):815-818. PubMed ID: 30773618
    [No Abstract]   [Full Text] [Related]  

  • 14. Translational Research and Drug Development in Psoriasis by Collaborative Efforts of Academia and Industry.
    van de Kerkhof PCM
    J Invest Dermatol; 2020 Mar; 140(3):524-526. PubMed ID: 31945346
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicting interests in Toronto: anatomy of a controversy at the interface of academia and industry.
    Healy DI
    Perspect Biol Med; 2002; 45(2):250-63. PubMed ID: 11919383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conflict of interest in industry-sponsored drug development.
    Emanuel EJ
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical issues for effective collaboration between academia and industry in the field of regenerative medicine in Japan.
    Tsubouchi M; Morishita R; Tabata Y; Matsui S; Kawakami K
    Regen Med; 2008 Jul; 3(4):497-504. PubMed ID: 18588472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unhealthy alliance between academia and corporate America.
    Andreopoulos S
    West J Med; 2001 Oct; 175(4):225-6. PubMed ID: 11577038
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflict of interest.
    Holmes DR; Firth BG; James A; Winslow R; Hodgson PK; Gamble GL; Popp RL; Harrington RA
    Am Heart J; 2004 Feb; 147(2):228-37. PubMed ID: 14760318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is academic medicine for sale?
    Angell M
    N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.